Wednesday, October 17, 2018 12:14:15 PM
We're currently waiting for the 1FQ19 10-Q (thru 7/31/18). 2FQ19 (thru 10/31/18) is almost over. I've been predicting for months that the first and second quarters won't set any records and would probably be pretty mediocre. The company's main revenue driver this year will be the NY hemp crop which is currently being harvested. Revenues from that harvest won't show up in the financials until 3FQ19 (thru 1/31/19) and 4FQ19 (thru 4/30/19). I'm holding to my prediction that FY19 revenues will surpass FY18's $7+ million.
It doesn't take a genius to figure out that until the revenues from the hemp harvest start showing up we may not see much improvement in the company's financials. However, watch for the OBITX spinoff to make a big splash and I'm sure Paul will have a few surprises (e.g. potential acquisitions and contracts) to keep things moving in the meantime.
Les
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM